Viveve Medical, Inc.
VIVE · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $72,524,788 | $69,803,687 | $112,572,806 | $115,022,831 |
| - Cash | $5,907 | $9,431 | $14,045 | $19,162 |
| + Debt | $5,881 | $5,697 | $5,519 | $5,349 |
| Enterprise Value | $72,524,762 | $69,799,953 | $112,564,280 | $115,009,018 |
| Revenue | $1,684 | $1,795 | $1,641 | $1,706 |
| % Growth | -6.2% | 9.4% | -3.8% | – |
| Gross Profit | $546 | $294 | $320 | -$41 |
| % Margin | 32.4% | 16.4% | 19.5% | -2.4% |
| EBITDA | -$4,510 | -$4,872 | -$5,290 | -$5,754 |
| % Margin | -267.8% | -271.4% | -322.4% | -337.3% |
| Net Income | -$5,290 | -$6,123 | -$6,177 | -$6,328 |
| % Margin | -314.1% | -341.1% | -376.4% | -370.9% |
| EPS Diluted | -0.5 | -0.58 | -0.58 | -0.63 |
| % Growth | 13.8% | 0% | 7.9% | – |
| Operating Cash Flow | -$3,350 | -$4,568 | -$5,087 | -$3,227 |
| Capital Expenditures | -$193 | -$59 | -$49 | -$294 |
| Free Cash Flow | -$3,543 | -$4,627 | -$5,136 | -$3,521 |